Legumain is a cysteine protease that contributes to the development of several neurodegenerative diseases by cleaving specific substrates, impairing physiological function, or producing pathogenic fragment proteins (Zhang et al., 2014, 2017; Zhang, Song, et al., 2015). This evidence concerns the gene CTSB and neurodegenerative disease.